What are the lupus anticoagulant antibodies and what are examples of each?

Lupus Anticoagulant Antibodies: Names and Examples

Lupus anticoagulant (LA) is not a single antibody but rather a heterogeneous group of antiphospholipid antibodies that recognize phospholipid-binding protein complexes, primarily targeting beta-2-glycoprotein I (β2GPI) and prothrombin when bound to phospholipids 1.

Core Antiphospholipid Antibodies in APS Diagnosis

The three cornerstone antiphospholipid antibodies for diagnosing antiphospholipid syndrome include 1:

• Lupus anticoagulant (LA) - detected functionally through clot-based assays
• Anti-cardiolipin antibodies (aCL) - IgG, IgM, and IgA isotypes
• Anti-beta-2-glycoprotein I antibodies (aβ2GPI) - IgG, IgM, and IgA isotypes

Specific Target Antigens of Lupus Anticoagulant Antibodies

LA antibodies are heterogeneous immunoglobulins (IgG, IgM, and/or IgA) that recognize specific phospholipid-binding proteins 2, 3:

Primary Targets:

1. Beta-2-glycoprotein I (β2GPI)-dependent antibodies

   • Most common type associated with autoimmune disease
   • Recognize β2GPI bound to anionic phospholipids 4
   • Amplify the anticoagulant effect of β2GPI itself 4

2. Prothrombin-dependent antibodies

   • Recognize prothrombin-phospholipid complexes 3
   • Increasingly recognized as central to LA activity 5
   • May contribute to thrombotic risk in APS patients 5

3. Annexin V-dependent antibodies

   • Less common but documented
   • Recognize annexin V-phospholipid complexes 3

Additional Antiphospholipid Antibodies (Emerging Role)

Beyond the core three, additional antibodies are gaining recognition 1:

• Anti-phosphatidylserine/prothrombin antibodies (aPS/PT)

  • IgG and IgM isotypes
  • IgM isotype strongly correlates with high LA titers 6
  • Emerging role in clinical practice

• Anti-domain I beta-2-glycoprotein I antibodies (aDI)

  • Target specific domain of β2GPI
  • Subject of recent studies 1

Key Distinguishing Features

Important caveat: LA antibodies associated with autoimmune disease differ fundamentally from those in infectious conditions. Autoimmune LA antibodies are β2GPI-dependent and cause anticoagulant effects, while syphilis-associated antibodies recognize cardiolipin alone without β2GPI and lack anticoagulant activity 4.

Detection Methods

LA is identified through functional clot-based assays rather than direct antibody measurement 1:

• Dilute Russell's viper venom time (dRVVT) - most commonly used
• LA-sensitive activated partial thromboplastin time (APTT) - using silica as activator
• Both assays should be performed in parallel to detect the heterogeneous LA population 1

The combination of dRVVT and APTT detects LA in up to 55% of triple-positive samples that would be missed by either test alone 1.